PLYGF (PolyPeptide Group AG) Change In Inventory: $-12.7 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

PLYGF PolyPeptide Group AG PLYGF
61 GF Score
Price $43.00
GF Value $40.84
Valuation Fairly Valued
! 9 Warning Signs
View Full Analysis

What is PolyPeptide Group AG Change In Inventory?

PolyPeptide Group AG PLYGF 61 Change In Inventory is $-12.7 Mil as of Dec. 2025. GuruFocus rates PLYGF with a GF Score™ of 61/100 and a GF Value™ of $40.84 (Fairly Valued). The stock has 9 warning signs investors should review.

PolyPeptide Group AG's change in inventory for the quarter that ended in Dec. 2025 was $4.7 Mil. It means PolyPeptide Group AG's inventory declined by $4.7 Mil from Jun. 2025 to Dec. 2025 .

PolyPeptide Group AG's change in inventory for the fiscal year that ended in Dec. 2025 was $-13.0 Mil. It means PolyPeptide Group AG's inventory increased by $13.0 Mil from Dec. 2024 to Dec. 2025 .

PolyPeptide Group AG's Total Inventories for the quarter that ended in Dec. 2025 was $180.6 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. PolyPeptide Group AG's Days Inventory for the quarter that ended in Dec. 2025 was 164.20.

Inventory Turnover measures how fast the company turns over its inventory within a year. PolyPeptide Group AG's Inventory Turnover for the quarter that ended in Dec. 2025 was 1.11.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. PolyPeptide Group AG's Inventory-to-Revenue for the quarter that ended in Dec. 2025 was 0.69.

PolyPeptide Group AG  (OTCPK:PLYGF) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

PolyPeptide Group AG's Days Inventory for the quarter that ended in is calculated as:

Days Inventory=Average Total Inventories/Cost of Goods Sold*Days in Period
=181.243/201.438*365 / 2
=164.20

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

PolyPeptide Group AG's Inventory Turnover for the quarter that ended in Dec. 2025 is calculated as

Inventory Turnover=Cost of Goods Sold / Average Total Inventories
=201.438 / 181.243
=1.11

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

PolyPeptide Group AG's Inventory to Revenue for the quarter that ended in Dec. 2025 is calculated as

Inventory-to-Revenue=Average Total Inventories / Revenue
=181.243 / 262.614
=0.69

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PolyPeptide Group AG Change In Inventory Related Terms

PolyPeptide Group AG Change In Inventory Historical Data

* Premium members only.

The historical data trend for PolyPeptide Group AG's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PolyPeptide Group AG Change In Inventory Chart

PolyPeptide Group AG Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Change In Inventory
Get a 7-Day Free Trial -19.97 -35.09 16.92 -17.77 -13.00

PolyPeptide Group AG Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Change In Inventory Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 24.24 -33.58 14.90 -17.47 4.74
PLYGF
61GF Score
PolyPeptide Group AG PLYGF
Change In Inventory is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PolyPeptide Group AG Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-12.7 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Change In Inventory →
What does a Change In Inventory of $-12.7 Mil mean?
PolyPeptide Group AG (PLYGF) has a Change In Inventory of $-12.7 Mil as of Dec. 2025. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for PolyPeptide Group AG and its competitors.
Is PolyPeptide Group AG's Change In Inventory too high?
PolyPeptide Group AG's current Change In Inventory is $-12.7 Mil. Overall, PolyPeptide Group AG has a GF Score™ of 61/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does PolyPeptide Group AG's Change In Inventory compare to ZTS and UTHR?
PolyPeptide Group AG's Change In Inventory of $-12.7 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Inventory for a Drug Manufacturers company?
A good Change In Inventory depends on the Drug Manufacturers industry context. However, Change In Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Inventory mean?
A high Change In Inventory can signal that a stock is expensive relative to its fundamentals. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for PolyPeptide Group AG and its competitors. PolyPeptide Group AG's current Change In Inventory is $-12.7 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PolyPeptide Group AG stock overvalued right now?
Based on GuruFocus' analysis, PolyPeptide Group AG (PLYGF) is currently considered Fairly Valued. The stock's GF Value™ is $40.84, compared to a current price of $43.00 — trading 5.3% above its estimated fair value. The current Change In Inventory is $-12.7 Mil. PolyPeptide Group AG's overall GF Score™ is 61/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Inventory calculated?
Change In Inventory is calculated from a company's financial statements. For PolyPeptide Group AG (PLYGF), the current Change In Inventory is $-12.7 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PolyPeptide Group AG (PLYGF) Overvalued in 2026?

Based on GuruFocus' analysis, PolyPeptide Group AG stock appears to be overvalued. The current stock price of $43.00 is trading 5.3% above its estimated GF Value™ of $40.84. GuruFocus considers PolyPeptide Group AG to be Fairly Valued.

Key valuation signals for PLYGF:

  • Change In Inventory: $-12.7 Mil
  • GF Value™: $40.84 vs. price of $43.00 (5.3% above fair value)
  • GF Score™: 61/100 with 9 warning signs

No single metric tells the full story. See the PLYGF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

PolyPeptide Group AG Business Description

Address Neuhofstrasse 24, Baar, Zug, CHE, 6340
PolyPeptide Group AG is an independent contract development and manufacturing organization (CDMO) focused on peptides and oligonucleotides employed as an active pharmaceutical ingredients (APIs) and used as intermediates in therapeutic products. The company derives majority of its revenue from Europe and Asia.
61GF Score

Get the complete analysis for PLYGF

Change In Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$43.00
Price
$40.84
GF Value